sarsassoci
human
coronaviru
sarshcov
newli
describ
emerg
viru
conclus
establish
etiolog
agent
sever
acut
respiratori
syndrom
sar
studi
present
singletub
rtpcr
assay
detect
high
analyt
sensit
sarshcov
well
sever
coronavirus
includ
known
human
respiratori
coronavirus
speci
identif
provid
sequenc
amplicon
although
rapid
screen
test
restrict
enzym
analysi
prove
use
analysi
sampl
obtain
sar
outbreak
toronto
canada
sever
acut
respiratori
syndrom
sar
newli
describ
emerg
infecti
diseas
present
high
fever
atyp
pneumonia
diseas
first
appear
guangdong
provinc
china
quickli
spread
countri
outbreak
report
mainland
china
vietnam
singapor
hong
kong
taiwan
canada
drazen
lee
et
al
poutanen
et
al
tsang
et
al
vu
et
al
new
previous
unknown
coronaviru
first
isol
patient
sar
univers
hongkong
peiri
et
al
quickli
follow
report
sever
laboratori
demonstr
new
coronaviru
sampl
patient
sar
drosten
et
al
ksiazek
et
al
poutanen
et
al
complet
genom
sequenc
viru
determin
marra
et
al
rota
et
al
confirm
classif
sarsassoci
agent
new
coronaviru
distinct
previous
known
group
coronaviru
marra
et
al
rota
et
al
relationship
group
snijder
et
al
experiment
infect
cynomolg
monkey
permit
fulfil
koch
postul
pathogen
firmli
establish
sarsassoci
human
coronaviru
sarshcov
etiolog
agent
sar
studi
present
rtpcr
protocol
allow
detect
sarshcov
clinic
sampl
singletub
rtpcr
base
consensu
primer
target
conserv
region
coronaviru
genom
sequenc
allow
detect
speci
identif
sever
coronavirus
includ
sarshcov
high
analyt
sensit
assay
expect
help
fulfil
world
health
organ
laboratori
case
see
front
matter
elsevi
bv
right
reserv
definit
sar
recommend
use
two
differ
pcr
assay
addit
even
sarshcov
reappear
human
popul
assay
still
use
sinc
provid
diagnost
test
respiratori
coronavirus
rna
extract
trizol
reagent
life
technolog
per
manufactur
recommend
lung
biopsi
patient
sar
rna
pellet
resuspend
l
mm
dithiotreitol
vv
rnasin
ul
promega
serial
dilut
aliquot
frozen
c
quantif
rna
serial
dilut
achiev
measur
amount
sarshcov
rna
aliquot
realart
hpa
coronaviru
rtpcr
artu
gmbh
hamburg
germani
human
coronavirus
strain
initi
obtain
atcc
passag
cell
cultur
describ
sizun
et
al
stock
virus
titrat
describ
sizun
et
al
rna
extract
titrat
stock
use
trizol
life
technolog
per
manufactur
recommend
serial
dilut
tissu
cultureadapt
infecti
bronchiti
viru
ibv
stock
strain
massachusset
strain
baudett
obtain
dr
e
nagi
ontario
veterinari
colleg
univers
guelph
ontario
rna
extract
serial
dilut
sar
outbreak
toronto
sever
sampl
patient
probabl
suspect
sar
refer
laboratori
sarshcov
detect
rtpcr
assay
use
new
primer
describ
includ
lung
biopsi
bronchoalveolar
lavag
nasopharyng
swab
throat
swab
pleural
fluid
sampl
endotrach
aspir
blood
sampl
stool
sampl
urin
sampl
rna
extract
lung
tissu
use
rneasi
kit
qiagen
per
manufactur
recommend
sampl
rna
extract
use
guanidium
thiocyan
buffer
gtc
extract
method
describ
johnson
et
al
primer
design
target
segment
pol
code
region
conserv
among
sever
speci
coronaviru
fig
use
sens
primer
tga
tgg
gtt
ggg
act
atc
cta
aat
gtg
antisens
primer
gta
gtt
gca
tca
ccg
gaa
gtt
gtg
cca
homolog
segment
sequenc
strain
sarshcov
genbank
access
number
respect
done
use
qiagen
onestep
rtpcr
kit
reaction
perform
ml
tube
diam
pre
total
volum
l
overlaid
l
miner
oil
reaction
mix
contain
l
qiagen
buffer
l
dntp
mix
dntp
mm
concentr
l
primer
stock
l
molecular
grade
doubl
distil
water
ddh
l
onestep
enzym
mix
qiagen
master
mix
aliquot
tube
l
templat
rna
ad
pcr
thermal
cycl
done
stratagen
robocycl
initi
incub
c
min
follow
incub
c
min
cycl
consist
denatur
c
min
anneal
c
min
elong
c
min
extens
precaut
pcr
contamin
previous
describ
johnson
et
al
strictli
observ
posit
neg
control
well
extract
control
control
pcr
inhibit
set
essenti
describ
johnson
et
al
l
volum
reaction
submit
electrophoresi
agaros
nusiev
biowhittak
molecular
applic
rockland
usa
gel
contain
ethidium
bromid
gel
visual
uv
transillumin
photograph
reaction
mixtur
expect
bp
amplicon
detect
digest
restrict
enzym
alui
cut
within
sequenc
agct
digest
reaction
consist
l
rtpcr
mixtur
l
enzym
buffer
l
alui
ul
new
england
biolab
l
ddh
total
l
reaction
incub
c
h
analyz
agaros
gel
electrophoresi
amplicon
submit
autom
sequenc
strand
use
pcr
primer
sequenc
primer
dot
denot
homolog
consensu
sequenc
top
sequenc
align
calcul
use
clustalx
window
version
thompson
et
al
edit
genedoc
version
window
nichola
kb
sequenc
perform
dna
sequenc
facil
centr
appli
genom
hospit
sick
children
sequenc
edit
analysi
done
use
program
generunn
window
version
hast
softwar
sequenc
align
calcul
use
clustalx
window
version
thompson
et
al
default
paramet
gap
open
gap
extens
phylogenet
tree
infer
use
treecon
window
version
van
de
peer
de
wachter
use
distanc
method
brief
distanc
calcul
without
correct
tree
topolog
infer
neighbor
join
method
tree
reroot
internod
bootstrap
analys
done
replic
initi
amino
acid
sequenc
align
pol
openread
frame
orf
use
identifi
wellconserv
region
across
speci
coronavirus
compris
sarshcov
member
three
previous
describ
group
coronavirus
correspond
nucleotid
align
use
design
pcr
primer
target
wellconserv
region
fig
illustr
align
nt
segment
coronaviru
sequenc
homolog
segment
strain
sarshcov
well
correspond
sequenc
newli
describ
human
coronaviru
fouchier
et
al
van
der
hoek
et
al
along
sequenc
primer
fig
illustr
phylogenet
tree
nucleotid
sequenc
fig
amino
acid
sequenc
fig
segment
demonstr
enough
sequenc
divers
region
bracket
primer
allow
unambigu
speci
identif
use
templat
rna
sarshcov
well
rna
two
strain
ibv
could
readili
reproduc
obtain
expect
bp
amplicon
aliquot
serial
rna
dilut
prepar
lung
biopsi
sampl
patient
sar
see
section
use
compar
assay
realart
hpa
coronaviru
rtpcr
artu
gmbh
result
display
tabl
show
assay
essenti
sensit
realart
hpa
coronaviru
rtpcr
assay
estim
analyt
sensit
genom
copi
viral
rna
could
detect
littl
tcid
tissu
cultur
infect
dose
viral
rna
could
detect
littl
tcid
coronavirus
test
studi
speci
verifi
sequenc
case
sequenc
intern
primer
ident
expect
sequenc
base
expect
sequenc
amplicon
rapid
screen
test
speci
identif
human
coronavirus
design
use
alui
restrict
enzym
illustr
fig
sarshcov
amplicon
cut
fragment
amplicon
fragment
amplicon
cut
alui
base
refer
sequenc
amplicon
ibv
would
contain
alui
site
nucleic
acid
human
tissu
respiratori
virus
whose
presenc
detect
variou
sampl
includ
influenza
respiratori
syncyti
viru
parainfluenza
adenovirus
gener
amplicon
bp
clinic
sampl
list
presenc
sarshcov
rna
demonstr
one
lung
biopsi
two
bronchoalveolar
lavag
two
nasopharyng
swab
two
urin
sampl
one
throat
swab
tabl
comparison
rtpcr
assay
realart
hpa
coronaviru
rtpcr
artu
gmbh
dilut
rtpcr
realart
hpa
coronaviru
rtpcr
genom
copi
column
two
show
result
score
posit
neg
obtain
assay
use
l
indic
rna
dilut
see
section
dilut
assay
done
two
differ
aliquot
result
agreement
column
three
show
averag
two
experi
measur
number
genom
copi
l
rna
dilut
realart
hpa
coronaviru
rtpcr
studi
present
singletub
rtpcr
assay
design
detect
sever
speci
coronavirus
includ
sar
coronavirus
use
consensu
primer
design
align
sequenc
region
pol
orf
speci
coronavirus
previou
version
primer
base
align
four
speci
coronavirus
bern
toroviru
use
demonstr
presenc
new
coronaviru
patient
sar
canada
kumar
et
al
poutanen
et
al
time
complet
sequenc
sar
coronaviru
still
unknown
use
revis
primer
optim
rtpcr
led
improv
analyt
sensit
three
order
magnitud
compar
previou
assay
sensit
proven
suffici
detect
sarshcov
sever
clinic
sampl
assay
design
broadli
reactiv
genom
mani
coronaviru
speci
demonstr
detect
coronavirus
four
known
group
coronavirus
includ
wellrecogn
human
pathogen
holm
although
known
coronaviru
speci
test
expect
primer
pair
amplifi
high
analyt
sensit
target
genom
segment
speci
use
design
primer
possibl
except
porcin
epidem
diarrhea
viru
pedv
whose
sequenc
mismatch
third
nt
end
primer
fig
current
assay
detect
high
sensit
three
coronavirus
known
infect
human
sequenc
amplicon
would
unambigu
identifi
speci
fig
although
yet
opportun
test
assay
isol
newli
describ
van
der
hoek
et
al
predict
base
sequenc
align
fig
rtpcr
assay
would
also
detect
sequenc
amplicon
follow
phylogenet
analysi
fig
would
readili
confirm
ident
viru
base
publish
sequenc
digest
amplicon
alui
would
yield
distinct
pattern
consist
band
bp
bp
sinc
sequenc
target
primer
conserv
across
sever
coronaviru
speci
particularli
clear
amino
acid
level
suggest
strong
select
pressur
part
genom
turn
suggest
assay
would
still
abl
detect
mutant
variant
strain
sarshcov
mutat
would
like
occur
region
target
primer
date
variou
isol
sarshcov
display
great
genet
homogen
ruan
et
al
argu
emerg
sarshcov
human
popul
recent
howev
viru
emerg
allow
propag
genet
divers
may
well
increas
although
genom
mani
known
coronavirus
appear
rel
stabl
note
blast
search
genbank
databas
use
segment
sarshcov
fig
show
homolog
sequenc
sarshcov
deposit
date
includ
repres
cluster
guan
et
al
homolog
greater
two
sequenc
sarshcov
well
recent
sar
outbreak
suggest
coronavirus
may
emerg
new
human
pathogen
assum
conserv
sequenc
target
primer
stem
strong
evolutionari
constraint
rtpcr
assay
describ
would
like
detect
emerg
coronaviru
studi
simpl
restrict
enzym
analysi
screen
test
shown
help
identifi
sarshcov
inde
sampl
test
posit
sarshcov
laboratori
toronto
outbreak
expect
restrict
pattern
demonstr
base
sequenc
deposit
genbank
pattern
would
demonstr
isol
sarshcov
sequenc
date
howev
rna
viru
genom
much
variabl
dna
viru
genom
one
reli
complet
analysi
failur
obtain
expect
digest
fragment
amplicon
cut
case
prompt
determin
sequenc
amplicon
illustr
case
point
wherea
amplicon
ibv
strain
baudett
cleav
alui
amplicon
strain
massachussett
fact
cleav
alui
verifi
sequenc
digest
amplicon
data
shown
sequenc
amplicon
comparison
sequenc
sever
coronavirus
phylogenet
analysi
fig
permit
definit
identif
inde
new
coronaviru
emerg
appear
like
could
detect
identifi
new
viru
use
rtpcr
assay
follow
sequenc
phylogenet
analysi
sinc
end
global
sar
outbreak
total
three
laboratori
confirm
sporad
case
sar
guangdong
occur
howev
spread
well
three
laboratori
acquir
incid
normil
surveil
sar
still
recommend
great
concern
neg
impact
fals
posit
laboratori
test
world
health
organ
recommend
protocol
laboratori
diagnosi
sar
post
outbreak
period
includ
use
two
differ
rtpcr
assay
assay
describ
provid
altern
test
help
regard
furthermor
assay
detect
sever
coronavirus
quit
feasibl
use
rna
coronaviru
sarshcov
posit
control
fact
laboratori
use
posit
control
rna
transcrib
clone
amplicon
ibv
ibv
never
implic
human
infect
use
ibv
posit
control
remov
potenti
sourc
pcr
contamin
sarshcov
genet
materi
laboratori
studi
presenc
sarshcov
demonstr
varieti
clinic
sampl
illustr
use
assay
number
posit
sampl
report
small
draw
firm
conclus
take
account
distinct
probabl
suspect
case
sar
well
previou
observ
made
earlier
laboratori
outbreak
appear
sarshcov
like
demonstr
lower
respiratori
tract
sampl
bronchoalveolar
lavag
lung
biopsi
rather
nasopharyng
swab
parallel
find
report
peiri
et
al
tang
et
al
suggest
sarshcov
appear
high
titer
nasopharynx
rel
late
diseas
peiri
et
al
thu
neg
rtpcr
result
sampl
reflect
poor
analyt
sensit
assay
rather
biolog
viru
systemat
studi
variou
sampl
obtain
throughout
cours
diseas
sever
patient
requir
determin
best
test
algorithm
certainli
control
outbreak
toronto
care
establish
epidemiolog
link
patient
fit
case
definit
seem
effect
method
laboratori
confirm
case
chain
also
prove
help
wallington
et
al
summari
singletub
rtpcr
assay
detect
human
coronavirus
includ
sarshcov
develop
expect
remain
effect
possibl
sarshcov
mutant
valu
new
coronavirus
emerg
human
pathogen
